img

Global Asthma Medication Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Asthma Medication Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Asthma Medication report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Asthma Medication market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Children and Adolescent are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Asthma Medication industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Asthma Medication key manufacturers include Dulera, QVAR, Glaxosmithkline plc, MAP Pharmaceuticals,Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc and Sepracor, Inc, etc. Dulera, QVAR, Glaxosmithkline plc are top 3 players and held % sales share in total in 2022.
Asthma Medication can be divided into Quick-Relief Medications, Long-Term Control Medications and Asthma Medications During Pregnancy,, etc. Quick-Relief Medications is the mainstream product in the market, accounting for % sales share globally in 2022.
Asthma Medication is widely used in various fields, such as Children, Adolescent and Adult,, etc. Children provides greatest supports to the Asthma Medication industry development. In 2022, global % sales of Asthma Medication went into Children filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Asthma Medication market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Dulera
QVAR
Glaxosmithkline plc
MAP Pharmaceuticals,Inc
Merck & Co. Inc
AstraZeneca plc
Roche Holdings Ltd
Genentech Inc
Sepracor, Inc
Schering-Plough Corp
Sanofi-Aventis
Theravance Inc
Segment by Type
Quick-Relief Medications
Long-Term Control Medications
Asthma Medications During Pregnancy

Segment by Application


Children
Adolescent
Adult

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Asthma Medication market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Asthma Medication, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Asthma Medication industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Asthma Medication in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Asthma Medication introduction, etc. Asthma Medication Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Asthma Medication market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Asthma Medication Market Overview
1.1 Asthma Medication Product Overview
1.2 Asthma Medication Market Segment by Type
1.2.1 Quick-Relief Medications
1.2.2 Long-Term Control Medications
1.2.3 Asthma Medications During Pregnancy
1.3 Global Asthma Medication Market Size by Type
1.3.1 Global Asthma Medication Market Size Overview by Type (2018-2034)
1.3.2 Global Asthma Medication Historic Market Size Review by Type (2018-2024)
1.3.3 Global Asthma Medication Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Asthma Medication Sales Breakdown by Type (2018-2024)
1.4.2 Europe Asthma Medication Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Asthma Medication Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Asthma Medication Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Asthma Medication Sales Breakdown by Type (2018-2024)
2 Global Asthma Medication Market Competition by Company
2.1 Global Top Players by Asthma Medication Sales (2018-2024)
2.2 Global Top Players by Asthma Medication Revenue (2018-2024)
2.3 Global Top Players by Asthma Medication Price (2018-2024)
2.4 Global Top Manufacturers Asthma Medication Manufacturing Base Distribution, Sales Area, Product Type
2.5 Asthma Medication Market Competitive Situation and Trends
2.5.1 Asthma Medication Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Asthma Medication Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Asthma Medication as of 2022)
2.7 Date of Key Manufacturers Enter into Asthma Medication Market
2.8 Key Manufacturers Asthma Medication Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Asthma Medication Status and Outlook by Region
3.1 Global Asthma Medication Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Asthma Medication Historic Market Size by Region
3.2.1 Global Asthma Medication Sales in Volume by Region (2018-2024)
3.2.2 Global Asthma Medication Sales in Value by Region (2018-2024)
3.2.3 Global Asthma Medication Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Asthma Medication Forecasted Market Size by Region
3.3.1 Global Asthma Medication Sales in Volume by Region (2024-2034)
3.3.2 Global Asthma Medication Sales in Value by Region (2024-2034)
3.3.3 Global Asthma Medication Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Asthma Medication by Application
4.1 Asthma Medication Market Segment by Application
4.1.1 Children
4.1.2 Adolescent
4.1.3 Adult
4.2 Global Asthma Medication Market Size by Application
4.2.1 Global Asthma Medication Market Size Overview by Application (2018-2034)
4.2.2 Global Asthma Medication Historic Market Size Review by Application (2018-2024)
4.2.3 Global Asthma Medication Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Asthma Medication Sales Breakdown by Application (2018-2024)
4.3.2 Europe Asthma Medication Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Asthma Medication Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Asthma Medication Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Asthma Medication Sales Breakdown by Application (2018-2024)
5 North America Asthma Medication by Country
5.1 North America Asthma Medication Historic Market Size by Country
5.1.1 North America Asthma Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Asthma Medication Sales in Volume by Country (2018-2024)
5.1.3 North America Asthma Medication Sales in Value by Country (2018-2024)
5.2 North America Asthma Medication Forecasted Market Size by Country
5.2.1 North America Asthma Medication Sales in Volume by Country (2024-2034)
5.2.2 North America Asthma Medication Sales in Value by Country (2024-2034)
6 Europe Asthma Medication by Country
6.1 Europe Asthma Medication Historic Market Size by Country
6.1.1 Europe Asthma Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Asthma Medication Sales in Volume by Country (2018-2024)
6.1.3 Europe Asthma Medication Sales in Value by Country (2018-2024)
6.2 Europe Asthma Medication Forecasted Market Size by Country
6.2.1 Europe Asthma Medication Sales in Volume by Country (2024-2034)
6.2.2 Europe Asthma Medication Sales in Value by Country (2024-2034)
7 Asia-Pacific Asthma Medication by Region
7.1 Asia-Pacific Asthma Medication Historic Market Size by Region
7.1.1 Asia-Pacific Asthma Medication Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Asthma Medication Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Asthma Medication Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Asthma Medication Forecasted Market Size by Region
7.2.1 Asia-Pacific Asthma Medication Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Asthma Medication Sales in Value by Region (2024-2034)
8 Latin America Asthma Medication by Country
8.1 Latin America Asthma Medication Historic Market Size by Country
8.1.1 Latin America Asthma Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Asthma Medication Sales in Volume by Country (2018-2024)
8.1.3 Latin America Asthma Medication Sales in Value by Country (2018-2024)
8.2 Latin America Asthma Medication Forecasted Market Size by Country
8.2.1 Latin America Asthma Medication Sales in Volume by Country (2024-2034)
8.2.2 Latin America Asthma Medication Sales in Value by Country (2024-2034)
9 Middle East and Africa Asthma Medication by Country
9.1 Middle East and Africa Asthma Medication Historic Market Size by Country
9.1.1 Middle East and Africa Asthma Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Asthma Medication Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Asthma Medication Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Asthma Medication Forecasted Market Size by Country
9.2.1 Middle East and Africa Asthma Medication Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Asthma Medication Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Dulera
10.1.1 Dulera Company Information
10.1.2 Dulera Introduction and Business Overview
10.1.3 Dulera Asthma Medication Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Dulera Asthma Medication Products Offered
10.1.5 Dulera Recent Development
10.2 QVAR
10.2.1 QVAR Company Information
10.2.2 QVAR Introduction and Business Overview
10.2.3 QVAR Asthma Medication Sales, Revenue and Gross Margin (2018-2024)
10.2.4 QVAR Asthma Medication Products Offered
10.2.5 QVAR Recent Development
10.3 Glaxosmithkline plc
10.3.1 Glaxosmithkline plc Company Information
10.3.2 Glaxosmithkline plc Introduction and Business Overview
10.3.3 Glaxosmithkline plc Asthma Medication Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Glaxosmithkline plc Asthma Medication Products Offered
10.3.5 Glaxosmithkline plc Recent Development
10.4 MAP Pharmaceuticals,Inc
10.4.1 MAP Pharmaceuticals,Inc Company Information
10.4.2 MAP Pharmaceuticals,Inc Introduction and Business Overview
10.4.3 MAP Pharmaceuticals,Inc Asthma Medication Sales, Revenue and Gross Margin (2018-2024)
10.4.4 MAP Pharmaceuticals,Inc Asthma Medication Products Offered
10.4.5 MAP Pharmaceuticals,Inc Recent Development
10.5 Merck & Co. Inc
10.5.1 Merck & Co. Inc Company Information
10.5.2 Merck & Co. Inc Introduction and Business Overview
10.5.3 Merck & Co. Inc Asthma Medication Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Merck & Co. Inc Asthma Medication Products Offered
10.5.5 Merck & Co. Inc Recent Development
10.6 AstraZeneca plc
10.6.1 AstraZeneca plc Company Information
10.6.2 AstraZeneca plc Introduction and Business Overview
10.6.3 AstraZeneca plc Asthma Medication Sales, Revenue and Gross Margin (2018-2024)
10.6.4 AstraZeneca plc Asthma Medication Products Offered
10.6.5 AstraZeneca plc Recent Development
10.7 Roche Holdings Ltd
10.7.1 Roche Holdings Ltd Company Information
10.7.2 Roche Holdings Ltd Introduction and Business Overview
10.7.3 Roche Holdings Ltd Asthma Medication Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Roche Holdings Ltd Asthma Medication Products Offered
10.7.5 Roche Holdings Ltd Recent Development
10.8 Genentech Inc
10.8.1 Genentech Inc Company Information
10.8.2 Genentech Inc Introduction and Business Overview
10.8.3 Genentech Inc Asthma Medication Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Genentech Inc Asthma Medication Products Offered
10.8.5 Genentech Inc Recent Development
10.9 Sepracor, Inc
10.9.1 Sepracor, Inc Company Information
10.9.2 Sepracor, Inc Introduction and Business Overview
10.9.3 Sepracor, Inc Asthma Medication Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Sepracor, Inc Asthma Medication Products Offered
10.9.5 Sepracor, Inc Recent Development
10.10 Schering-Plough Corp
10.10.1 Schering-Plough Corp Company Information
10.10.2 Schering-Plough Corp Introduction and Business Overview
10.10.3 Schering-Plough Corp Asthma Medication Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Schering-Plough Corp Asthma Medication Products Offered
10.10.5 Schering-Plough Corp Recent Development
10.11 Sanofi-Aventis
10.11.1 Sanofi-Aventis Company Information
10.11.2 Sanofi-Aventis Introduction and Business Overview
10.11.3 Sanofi-Aventis Asthma Medication Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Sanofi-Aventis Asthma Medication Products Offered
10.11.5 Sanofi-Aventis Recent Development
10.12 Theravance Inc
10.12.1 Theravance Inc Company Information
10.12.2 Theravance Inc Introduction and Business Overview
10.12.3 Theravance Inc Asthma Medication Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Theravance Inc Asthma Medication Products Offered
10.12.5 Theravance Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Asthma Medication Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Asthma Medication Industrial Chain Analysis
11.4 Asthma Medication Market Dynamics
11.4.1 Asthma Medication Industry Trends
11.4.2 Asthma Medication Market Drivers
11.4.3 Asthma Medication Market Challenges
11.4.4 Asthma Medication Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Asthma Medication Distributors
12.3 Asthma Medication Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Quick-Relief Medications
Table 2. Major Company of Long-Term Control Medications
Table 3. Major Company of Asthma Medications During Pregnancy
Table 4. Global Asthma Medication Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Asthma Medication Sales by Type (2018-2024) & (K Units)
Table 6. Global Asthma Medication Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Asthma Medication Sales by Type (2018-2024) & (US& Million)
Table 8. Global Asthma Medication Market Share in Value by Type (2018-2024)
Table 9. Global Asthma Medication Price by Type (2018-2024) & (USD/Unit)
Table 10. Global Asthma Medication Sales by Type (2024-2034) & (K Units)
Table 11. Global Asthma Medication Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Asthma Medication Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Asthma Medication Sales Market Share in Value by Type (2024-2034)
Table 14. Global Asthma Medication Price by Type (2024-2034) & (USD/Unit)
Table 15. North America Asthma Medication Sales by Type (2018-2024) & (K Units)
Table 16. North America Asthma Medication Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Asthma Medication Sales (K Units) by Type (2018-2024)
Table 18. Europe Asthma Medication Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Asthma Medication Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Asthma Medication Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Asthma Medication Sales (K Units) by Type (2018-2024)
Table 22. Latin America Asthma Medication Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Asthma Medication Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Asthma Medication Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Asthma Medication Sales by Company (2018-2024) & (K Units)
Table 26. Global Asthma Medication Sales Share by Company (2018-2024)
Table 27. Global Asthma Medication Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Asthma Medication Revenue Share by Company (2018-2024)
Table 29. Global Market Asthma Medication Price by Company (2018-2024) & (USD/Unit)
Table 30. Global Asthma Medication Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Asthma Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Asthma Medication as of 2022)
Table 33. Date of Key Manufacturers Enter into Asthma Medication Market
Table 34. Key Manufacturers Asthma Medication Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Asthma Medication Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Asthma Medication Sales by Region (2018-2024) & (K Units)
Table 38. Global Asthma Medication Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Asthma Medication Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Asthma Medication Sales Market Share in Value by Region (2018-2024)
Table 41. Global Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 42. Global Asthma Medication Sales by Region (2024-2034) & (K Units)
Table 43. Global Asthma Medication Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Asthma Medication Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Asthma Medication Sales Market Share in Value by Region (2024-2034)
Table 46. Global Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 47. Global Asthma Medication Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Asthma Medication Sales by Application (2018-2024) & (K Units)
Table 49. Global Asthma Medication Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Asthma Medication Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Asthma Medication Sales Market Share in Value by Application (2018-2024)
Table 52. Global Asthma Medication Price by Application (2018-2024) & (USD/Unit)
Table 53. Global Asthma Medication Sales by Application (2024-2034) & (K Units)
Table 54. Global Asthma Medication Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Asthma Medication Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Asthma Medication Sales Market Share in Value by Application (2024-2034)
Table 57. Global Asthma Medication Price by Application (2024-2034) & (USD/Unit)
Table 58. North America Asthma Medication Sales by Application (2018-2024) (K Units)
Table 59. North America Asthma Medication Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Asthma Medication Sales by Application (2018-2024) (K Units)
Table 61. Europe Asthma Medication Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Asthma Medication Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Asthma Medication Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Asthma Medication Sales by Application (2018-2024) (K Units)
Table 65. Latin America Asthma Medication Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Asthma Medication Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Asthma Medication Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Asthma Medication Sales by Country (2018-2024) & (K Units)
Table 69. North America Asthma Medication Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Asthma Medication Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Asthma Medication Sales Market Share in Value by Country (2018-2024)
Table 72. North America Asthma Medication Sales by Country (2024-2034) & (K Units)
Table 73. North America Asthma Medication Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Asthma Medication Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Asthma Medication Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Asthma Medication Sales by Country (2018-2024) & (K Units)
Table 77. Europe Asthma Medication Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Asthma Medication Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Asthma Medication Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Asthma Medication Sales by Country (2024-2034) & (K Units)
Table 81. Europe Asthma Medication Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Asthma Medication Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Asthma Medication Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Asthma Medication Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Asthma Medication Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Asthma Medication Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Asthma Medication Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Asthma Medication Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Asthma Medication Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Asthma Medication Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Asthma Medication Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Asthma Medication Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Asthma Medication Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Asthma Medication Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Asthma Medication Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Asthma Medication Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Asthma Medication Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Asthma Medication Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Asthma Medication Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Asthma Medication Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Asthma Medication Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Asthma Medication Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Asthma Medication Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Asthma Medication Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Asthma Medication Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Asthma Medication Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Asthma Medication Sales Market Share in Value by Country (2024-2034)
Table 108. Dulera Company Information
Table 109. Dulera Introduction and Business Overview
Table 110. Dulera Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Dulera Asthma Medication Product
Table 112. Dulera Recent Development
Table 113. QVAR Company Information
Table 114. QVAR Introduction and Business Overview
Table 115. QVAR Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. QVAR Asthma Medication Product
Table 117. QVAR Recent Development
Table 118. Glaxosmithkline plc Company Information
Table 119. Glaxosmithkline plc Introduction and Business Overview
Table 120. Glaxosmithkline plc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Glaxosmithkline plc Asthma Medication Product
Table 122. Glaxosmithkline plc Recent Development
Table 123. MAP Pharmaceuticals,Inc Company Information
Table 124. MAP Pharmaceuticals,Inc Introduction and Business Overview
Table 125. MAP Pharmaceuticals,Inc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. MAP Pharmaceuticals,Inc Asthma Medication Product
Table 127. MAP Pharmaceuticals,Inc Recent Development
Table 128. Merck & Co. Inc Company Information
Table 129. Merck & Co. Inc Introduction and Business Overview
Table 130. Merck & Co. Inc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Merck & Co. Inc Asthma Medication Product
Table 132. Merck & Co. Inc Recent Development
Table 133. AstraZeneca plc Company Information
Table 134. AstraZeneca plc Introduction and Business Overview
Table 135. AstraZeneca plc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. AstraZeneca plc Asthma Medication Product
Table 137. AstraZeneca plc Recent Development
Table 138. Roche Holdings Ltd Company Information
Table 139. Roche Holdings Ltd Introduction and Business Overview
Table 140. Roche Holdings Ltd Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Roche Holdings Ltd Asthma Medication Product
Table 142. Roche Holdings Ltd Recent Development
Table 143. Genentech Inc Company Information
Table 144. Genentech Inc Introduction and Business Overview
Table 145. Genentech Inc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Genentech Inc Asthma Medication Product
Table 147. Genentech Inc Recent Development
Table 148. Sepracor, Inc Company Information
Table 149. Sepracor, Inc Introduction and Business Overview
Table 150. Sepracor, Inc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Sepracor, Inc Asthma Medication Product
Table 152. Sepracor, Inc Recent Development
Table 153. Schering-Plough Corp Company Information
Table 154. Schering-Plough Corp Introduction and Business Overview
Table 155. Schering-Plough Corp Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. Schering-Plough Corp Asthma Medication Product
Table 157. Schering-Plough Corp Recent Development
Table 158. Sanofi-Aventis Company Information
Table 159. Sanofi-Aventis Introduction and Business Overview
Table 160. Sanofi-Aventis Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. Sanofi-Aventis Asthma Medication Product
Table 162. Sanofi-Aventis Recent Development
Table 163. Theravance Inc Company Information
Table 164. Theravance Inc Introduction and Business Overview
Table 165. Theravance Inc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 166. Theravance Inc Asthma Medication Product
Table 167. Theravance Inc Recent Development
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Asthma Medication Market Trends
Table 171. Asthma Medication Market Drivers
Table 172. Asthma Medication Market Challenges
Table 173. Asthma Medication Market Restraints
Table 174. Asthma Medication Distributors List
Table 175. Asthma Medication Downstream Customers
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Asthma Medication Product Picture
Figure 2. Global Asthma Medication Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Asthma Medication Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Asthma Medication Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Quick-Relief Medications
Figure 6. Global Quick-Relief Medications Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Long-Term Control Medications
Figure 8. Global Long-Term Control Medications Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Asthma Medications During Pregnancy
Figure 10. Global Asthma Medications During Pregnancy Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Global Asthma Medication Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Asthma Medication Sales Market Share by Type in 2022 & 2034
Figure 13. North America Asthma Medication Sales Market Share in Volume by Type in 2022
Figure 14. North America Asthma Medication Sales Market Share in Value by Type in 2022
Figure 15. Europe Asthma Medication Sales Market Share in Volume by Type in 2022
Figure 16. Europe Asthma Medication Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Asthma Medication Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Asthma Medication Sales Market Share in Value by Type in 2022
Figure 19. Latin America Asthma Medication Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Asthma Medication Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Asthma Medication Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Asthma Medication Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Asthma Medication Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Asthma Medication Revenue in 2022
Figure 25. Asthma Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Children
Figure 27. Global Children Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Adolescent
Figure 29. Global Adolescent Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Adult
Figure 31. Global Adult Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Global Asthma Medication Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Asthma Medication Sales Market Share by Application in 2022 & 2034
Figure 34. North America Asthma Medication Sales Market Share in Volume by Application in 2022
Figure 35. North America Asthma Medication Sales Market Share in Value by Application in 2022
Figure 36. Europe Asthma Medication Sales Market Share in Volume by Application in 2022
Figure 37. Europe Asthma Medication Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Asthma Medication Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Asthma Medication Sales Market Share in Value by Application in 2022
Figure 40. Latin America Asthma Medication Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Asthma Medication Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Asthma Medication Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Asthma Medication Manufacturing Cost Structure
Figure 45. Asthma Medication Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed